DARE Return on Tangible Equity | Dare Bioscience, Inc.

Dare Bioscience, Inc. (DARE) Return on Tangible Equity

2026-06-30: Return Tang Equity 1961.64%.
2026-03-31: Return Tang Equity -1636.71%.
2025-12-31: Return Tang Equity -471.37%.
2025-09-30: Return Tang Equity -611.08%.

Complete source-backed return tang equity history.

Available history: 2012-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	1961.64%
2026-03-31	-1636.71%
2025-12-31	-471.37%
2025-09-30	-611.08%
2025-06-30	146.10%
2025-03-31	17.53%
2024-12-31	67.42%
2024-09-30	242.83%
2024-06-30	-269.56%
2024-03-31	262.51%
2023-12-31	597.53%
2023-09-30	1793.43%
2023-06-30	1462.37%
2023-03-31	-615.33%
2022-12-31	-278.50%
2022-09-30	-93.18%
2022-06-30	-91.41%
2022-03-31	-128.80%
2021-12-31	-99.85%
2021-09-30	-117.90%
2021-06-30	-419.82%
2021-03-31	-935.24%
2020-12-31	2379.09%
2020-09-30	1647.01%
2020-06-30	-5987.37%
2020-03-31	-481.13%
2019-12-31	-3235.71%
2019-09-30	-735.58%
2019-06-30	-245.82%
2019-03-31	-320.74%
2018-12-31	-248.84%
2018-09-30	-523.63%
2018-06-30	-313.61%
2018-03-31	-178.19%
2017-12-31	-142.14%
2017-09-30	-26.94%
2017-06-30	-23.62%
2017-03-31	-146.23%
2016-12-31	3464.24%
2016-09-30	-211.36%
2016-06-30	-176.70%
2016-03-31	-124.25%
2015-12-31	84337.66%
2015-09-30	-61.99%
2015-06-30	-45.98%
2015-03-31	-71.41%
2014-12-31	-51.50%
2014-09-30	-36.84%
2014-06-30	-29.40%
2014-03-31	14.93%
2013-12-31	18.18%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-471.37%
2024-12-31	67.42%
2023-12-31	597.53%
2022-12-31	-278.50%
2021-12-31	-99.85%
2020-12-31	2379.09%
2019-12-31	-3235.71%
2018-12-31	-248.84%
2017-12-31	-141.92%
2016-12-31	94.66%
2015-12-31	84337.66%
2014-12-31	-51.50%
2013-12-31	18.18%
2012-12-31	27.61%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
KIORA PHARMACEUTICALS INC (KPRX)	United States	$0.012B
Scienture Holdings, Inc. (SCNX)	United States	$0.012B	-0.38
Phio Pharmaceuticals Corp. (PHIO)	United States	$0.012B	-0.92
ADIAL PHARMACEUTICALS, INC. (ADIL)	United States	$0.012B
Moleculin Biotech, Inc. (MBRX)	United States	$0.011B
MetaVia Inc. (MTVA)	United States	$0.011B	-0.65
KALA BIO, Inc. (KALA)	United States	$0.011B	-3.33
BIOVIE INC. (BIVI)	United States	$0.012B
Theriva Biologics, Inc. (TOVX)	United States	$0.011B
Aspire Biopharma Holdings, Inc. (ASBP)	United States	$0.012B	-0.60